2006
DOI: 10.1261/rna.2346806
|View full text |Cite
|
Sign up to set email alerts
|

Chlorolissoclimides: New inhibitors of eukaryotic protein synthesis

Abstract: Lissoclimides are cytotoxic compounds produced by shell-less molluscs through chemical secretions to deter predators. Chlorinated lissoclimides were identified as the active component of am arine extract from Pleurobranchus forskalii found during ah igh-throughput screening campaign to characterize new protein synthesis inhibitors. It was demonstrated that these compounds inhibit protein synthesis in vitro, in extracts prepared from mammalian and plant cells, as well as in vivo against mammalian cells. Our res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
34
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 55 publications
(35 citation statements)
references
References 30 publications
1
34
0
Order By: Relevance
“…CHX and BFA are more commonly used reagents than puromycin or nocodazole, and their latency and efficacy have been well documented. CHX prevents protein synthesis following just a few minutes of exposure (31); consistent with these reports, we indeed observed effects within 5 min. The inhibitory efficiency of CHX was judged by protein translation assays that reached ϳ90% of control cells exposed to CHX for 30 min.…”
Section: Discussionsupporting
confidence: 92%
“…CHX and BFA are more commonly used reagents than puromycin or nocodazole, and their latency and efficacy have been well documented. CHX prevents protein synthesis following just a few minutes of exposure (31); consistent with these reports, we indeed observed effects within 5 min. The inhibitory efficiency of CHX was judged by protein translation assays that reached ϳ90% of control cells exposed to CHX for 30 min.…”
Section: Discussionsupporting
confidence: 92%
“…Ribosome-binding assays were performed essentially as described previously (Robert et al 2006). Briefly, compound was preincubated with RRL at a final KCl concentration of 150 mM for 5 min, after which 32 P-labeled CAT mRNA was included.…”
Section: Ribosome-binding Assays and Polysome Profilingmentioning
confidence: 99%
“…tRNA-binding and translocation assays were performed essentially as described (SirDeshpande and Toogood 1995;Robert et al 2006). […”
Section: Trna-binding and Translocation Assaysmentioning
confidence: 99%
“…Benzimidazole3ibis HCV IRES domain II 10 µM [158] 23 Berenil Poly(rA).2poly(rU) RNA triplex/TAR 30 µM/K d not reported [159,160] 24 Biotin Biotin aptamer 6 µM 1f27 [161] 25 Blasticidin S PTC 1kc8 [162] 26 Carbomycin 50S subunit 88% inhibition of peptide analog binding at 100 µM 1k8a [163,164] 27 Chloramphenicol 50S subunit 2 µM 1k8a [152,165] 28 Chlorolissoclimide Inhibitor of translocation 0.7 µM (IC 50 ) [166] 29 Chlorpromazine HIV-1 TAR 0.1-1 mM 1lvj (related) [148] 30 Chlortetracycline Small subunit [167] 31 Clarithromycin PTC 6.2 nM (FPA) 1j5a [156,168] 32…”
Section: Numbermentioning
confidence: 99%
“…HIV-1 RRE <1 µM [176] 46 Delfinidin tRNA 10 µM [177] 47 Dichlorolissoclimide Inhibit eukaryotic protein synthesis 0.7 µM inhibition of protein synthesis only reported [166] 48 Doxycycline Small subunit fivefold tighter than tetracycline [167] 49 Erythromycin PTC 0.99 µM 1yi2 [178] 50 Ethidium bromide RNA/DNA heteroduplex, bulged RNA 3.3 µM [179,180] [189,190] 58 Hypoxanthine Guanine riboswitch 50 nM 2ees…”
Section: Db340mentioning
confidence: 99%